Literature DB >> 27260190

Chronic Pruritus and Connective Tissue Disorders: Review, Gaps, and Future Directions.

Jessica Sue Haber1, Rodrigo Valdes-Rodriguez1, Gil Yosipovitch2.   

Abstract

Chronic itch is a common skin manifestation in many connective tissue diseases. However, the cause of chronic itch in these diseases is still not fully understood. The complex, and in some cases incomplete understanding of, pathogenesis in each condition makes it difficult to target specific mediators of chronic itch. It is important to better understand the pathophysiology of chronic itch in these conditions, as this information might provide a fuller understanding of the pathogenesis of the diseases in general and lead to the development of more specific treatments for connective tissue diseases in patients with chronic itch. We present a review of the literature on what is known about the prevalence, possible pathophysiology, and effect on quality of life of chronic itch in patients with scleroderma, Sjögren's syndrome, dermatomyositis, systemic lupus erythematosus, cutaneous lupus erythematosus, and mixed connective tissue disease.

Entities:  

Mesh:

Year:  2016        PMID: 27260190     DOI: 10.1007/s40257-016-0201-9

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  3 in total

1.  Sicca Symptoms, Oral Health Conditions, Salivary Flow and Oral Candida in Sjögren's Syndrome Patients.

Authors:  Weini Xin; Katherine Chiu Man Leung; Edward Chin Man Lo; Mo Yin Mok; Moon Ho Leung
Journal:  Int J Environ Res Public Health       Date:  2020-05-21       Impact factor: 3.390

2.  The Relationship Between Ocular Itch, Ocular Pain, and Dry Eye Symptoms (An American Ophthalmological Society Thesis).

Authors:  Anat Galor; Leslie Small; William Feuer; Roy C Levitt; Konstantinos D Sarantopoulos; Gil Yosipovitch
Journal:  Trans Am Ophthalmol Soc       Date:  2018-01-17

Review 3.  Pruritus: A Sensory Symptom Generated in Cutaneous Immuno-Neuronal Crosstalk.

Authors:  Attila Gábor Szöllősi; Attila Oláh; Erika Lisztes; Zoltán Griger; Balázs István Tóth
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.